Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoannis Imbert

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Molecular Cancer Therapeutics|March 4, 2010
Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferationDavid J Schultz, Nalinie S Wickramasinghe, Margarita M Ivanova, et al.
Breast Cancer Research : BCR|June 25, 2026
Targeting PFKFB3 to enhance CDK4/6 inhibitor response in ER+ breast cancerSucheta Telang, Brian F Clem, Ariamna A Herrera Miret, et al.
Research Square|February 23, 2026
Targeting PFKFB3 to enhance CDK4/6 inhibitor response in ER+ breast cancerSucheta Telang, Brian F Clem, Ariamna A Herrera Miret, et al.
Molecular Cancer|August 25, 2012
Cytochrome c oxidase is activated by the oncoprotein Ras and is required for A549 lung adenocarcinoma growthSucheta Telang, Kristin K Nelson, Deanna L Siow, et al.
Molecular Cancer Therapeutics|May 16, 2013
Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancerBrian F Clem, Julie O'Neal, Gilles Tapolsky, et al.
Molecular and Cellular Biochemistry|May 17, 2020
PFKFB2 regulates glycolysis and proliferation in pancreatic cancer cellsSelahattin C Ozcan, Aybike Sarioglu, Tugba H Altunok, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Molecular Cancer Therapeutics|March 4, 2010
Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferationDavid J Schultz, Nalinie S Wickramasinghe, Margarita M Ivanova, et al.
Breast Cancer Research : BCR|June 25, 2026
Targeting PFKFB3 to enhance CDK4/6 inhibitor response in ER+ breast cancerSucheta Telang, Brian F Clem, Ariamna A Herrera Miret, et al.
Research Square|February 23, 2026
Targeting PFKFB3 to enhance CDK4/6 inhibitor response in ER+ breast cancerSucheta Telang, Brian F Clem, Ariamna A Herrera Miret, et al.
Molecular Cancer|August 25, 2012
Cytochrome c oxidase is activated by the oncoprotein Ras and is required for A549 lung adenocarcinoma growthSucheta Telang, Kristin K Nelson, Deanna L Siow, et al.
Molecular Cancer Therapeutics|May 16, 2013
Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancerBrian F Clem, Julie O'Neal, Gilles Tapolsky, et al.
Molecular and Cellular Biochemistry|May 17, 2020
PFKFB2 regulates glycolysis and proliferation in pancreatic cancer cellsSelahattin C Ozcan, Aybike Sarioglu, Tugba H Altunok, et al.
Pageof 3